Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qianbao Red Cough Granules
- Development stage
- Unknown
- Lead developer
- Chongqing Chuangnuo Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Qianbao Red Cough Granules is a proprietary Traditional Chinese Medicine (TCM) granules formulation developed by Chuangnuo Pharmaceutical Group and manufactured by its subsidiary, Jiangsu Chuangnuo Pharmaceutical. The product is based on the traditional 'Zhike Keli' (Cough Granules) formula, which is indicated for the treatment of cough, excessive phlegm, and fever associated with wind-heat or lung-heat syndromes. The formulation contains a synergistic blend of eight herbal and mineral ingredients: *Ephedra sinica*, *Bitter Apricot Seed* (Prunus armeniaca), *Gypsum fibrosum*, *Licorice* (Glycyrrhiza uralensis), *Mulberry Bark* (Morus alba), *Peucedanum praeruptorum*, *Platycodon grandiflorus*, and *Scutellaria baicalensis*. These components provide bronchodilatory, antitussive, expectorant, and anti-inflammatory effects. The 'Red' in the name likely refers to the manufacturer's former name, Jiangsu Hongyuan (Red Source) Pharmaceutical, or the product's distinctive red packaging.
- Brand names
- Qianbao Red Cough GranulesQianbao
- Other names
- Zhike KeliCough Granules千宝止咳颗粒
02
Targets
ADRA1A (α1A)β-AR (Beta-adrenergic receptor family)
Beyond the preview
Go deeper on Qianbao Red Cough Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qianbao Red Cough Granules.